Novartis AG ADS (NVS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Vasant Narasimhan
Employees:
101,700
LICHTSTRASSE 35, BASEL, SWITZERLAND CH 4056
01141613241111

Novartis AG researches, develops, manufactures, and markets healthcare products. The company operates through two segments, Innovative Medicines and Sandoz. Sandoz provides finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals.

Data derived from most recent annual or quarterly report
Market Cap 231.214 Billion Shares Outstanding2.366 Billion Avg 30-day Volume 1.596 Million
P/E Ratio23.4918 Dividend Yield3.6878 EPS3.19
Price to Revenue3.8003 Debt to Equity0.0303 EBITDA10.747 Billion
Price to Book Value3.3504 Operating Margin20.3455 Enterprise Value172.123 Billion
Current Ratio0.898 EPS Growth-0.304 Quick Ratio0.541
1 Yr BETA 0.3333 52-week High/Low 105.61 / 79.64 Profit Margin16.175
Operating Cash Flow Growth-59.0165 Free Cash Flow to Firm (FCFF) TTM 8.269 Billion Free Cash Flow to Equity (FCFE) TTM17.22 Billion
Altman Z-Score2.2362
View SEC Filings from NVS instead.

Novartis AG ADS YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NOVARTIS AG-SPONSORED ADR NVS 2023-11-28 13:45:04 UTC 4.9119 0.4081 1300000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-28 13:15:03 UTC 4.9119 0.4081 1300000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-28 12:45:04 UTC 4.9119 0.4081 1300000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 22:15:04 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 21:45:04 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 21:15:03 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 20:45:04 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 20:15:05 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 19:45:04 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 19:15:04 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 18:45:05 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 18:15:03 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 17:45:04 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 17:15:03 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 16:45:04 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 16:15:03 UTC 4.9119 0.4081 2700000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 15:45:04 UTC 4.9119 0.4081 1400000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 15:15:03 UTC 4.9119 0.4081 1400000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 14:45:03 UTC 5.0683 0.2517 1400000
NOVARTIS AG-SPONSORED ADR NVS 2023-11-27 14:15:04 UTC 5.0683 0.2517 1400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Congressional Transactions Past 6-Months

To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
senator Sheldon Whitehouse democrat Senate Filing 2023-10-17 2023-09-20 P $15,001-$50,000
Hon. Daniel Goldman House Filing 2023-08-04 2023-07-10 S $50,001-$100,000
WhaleWisdom Logo

Elevate your investments